MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
    • careers
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Beauty
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
WLKY: Medical marijuana advocates address legislators

WLKY: Medical marijuana advocates address legislators

by adminTorusBrand | Jun 18, 2014 | Company News, Media Coverage

CannaVest was mentioned in an article by WLKY by Kimberly Easton about medical marijuana advocates addressing legislators and pushing for legalization. “Eric Crawford is also in a lot of pain. A car accident left him a quadriplegic. “My life is a struggle...
CannaBANK Acquires Rights to License PharmaSphere’s Patented Growth System

CannaBANK Acquires Rights to License PharmaSphere’s Patented Growth System

by adminTorusBrand | Apr 12, 2012 | Company News, Press Releases

SAN DIEGO, April 12, 2012 /PRNewswire/ — CannaBANK Inc. is proud to announce it has acquired from PharmaSphere, LLC the rights to purchase the exclusive worldwide license for the use of TerraSphere Systems patented technology for any cannabis, hemp or...

Medical Marijuana Inc. (OTC: MJNA) Signs Final Term-Sheet to Purchase Cannabinoid (cannabis) Delivery Method for Deployment Into Pharmaceutical Market

by adminTorusBrand | Apr 4, 2012 | Company News, Industry Updates, Press Releases

Expanding MJNA’s Portfolio of Intellectual Property In The Medical Cannabinoid Market SAN DIEGO, April 4, 2012 /PRNewswire/ — Medical Marijuana Inc. (OTC: MJNA) is pleased to announce it has signed contracts with a European-based Pharmaceutical company for...

Medical Marijuana Inc. (OTC: MJNA) Completes Financing Agreement With CannaBANK Inc

by adminTorusBrand | Feb 28, 2012 | Company News, Industry Updates, Press Releases

SAN DIEGO, CA–(Business Wire – February 28, 2012) – Medical Marijuana Inc. (OTC: MJNA) is pleased to announce it has reached a finance agreement with CannaBANK Inc (CB) for up to four million dollars in equity for the acquisition and development of several...

Medical Marijuana Inc. (OTC: MJNA) Marijuana Extract Cannabidiol (CBD) Shows Therapeutic Benefit For Multiple Sclerosis (MS)

by adminTorusBrand | Sep 13, 2011 | Company News, Industry Updates, Press Releases

SAN DIEGO, CA–(Business Wire – Sept 13, 2011) – Medical Marijuana Inc (OTC: MJNA) is pleased to announce that studies from foundations and universities around the world have proven Cannabidiol (CBD) as a therapeutic treatment for Multiple Sclerosis...
« Older Entries

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.